Skip to search formSkip to main contentSkip to account menu

pranlukast

Known as: 8-(4 (4-phenylbutoxy)benzoyl)amino-2-(tetrazol-5'-yl)-4-oxo-4H-1-benzopyran, N-(4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-p-(4-phenylbutoxy)benzamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Allergic rhinitis is an allergic inflammation of the nasal mucosa due to sensitization to some inhalation allergens. There are… 
2007
2007
Are new diagnostic strategies providing answers? Thoracic oncology providers confronted with the task of diagnosing and… 
2005
2005
We thank Dr. Medford for an interest regarding our study.1 There has been a clinical interest in the use of leukotriene receptor… 
2005
2005
ABSTRACT Background Pranlukast and Montelukast are Cysteinyl leukotriene receptor antagonists with almost the same… 
2004
2004
Aim To determine whether pranlukast (ONO-1078), a cysteinyl leukotriene receptor antagonist, possesses therapeutic effect when… 
2004
2004
The aim of this study was to evaluate the effects of novel leukotriene antagonist, pranlukast hydrate on improvement of quality… 
2001
2001
We investigated the effects of the combination therapy of leukotriene receptor antagonist (Pranlukast) and an antihistamine… 
1996
1996
ARISE pulverized granules pranlukast-containing (A) and one or more saccharides (B) as essential ingredients and further…